These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20493936)

  • 21. Preparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitation.
    Zu Y; Sun W; Zhao X; Wang W; Li Y; Ge Y; Liu Y; Wang K
    Eur J Pharm Sci; 2014 Mar; 53():109-17. PubMed ID: 24345795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement.
    Sathigari SK; Radhakrishnan VK; Davis VA; Parsons DL; Babu RJ
    J Pharm Sci; 2012 Sep; 101(9):3456-64. PubMed ID: 22437488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What is a suitable dissolution method for drug nanoparticles?
    Heng D; Cutler DJ; Chan HK; Yun J; Raper JA
    Pharm Res; 2008 Jul; 25(7):1696-701. PubMed ID: 18320295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computer-Aided Design of Cefuroxime Axetil/Cyclodextrin System with Enhanced Solubility and Antimicrobial Activity.
    Mizera M; Szymanowska D; Stasiłowicz A; Siąkowska D; Lewandowska K; Miklaszewski A; Plech T; Tykarska E; Cielecka-Piontek J
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31878057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triboelectrification and dissolution property enhancements of solid dispersions.
    Asare-Addo K; Šupuk E; Al-Hamidi H; Owusu-Ware S; Nokhodchi A; Conway BR
    Int J Pharm; 2015 May; 485(1-2):306-16. PubMed ID: 25772415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
    Rahman Z; Zidan AS; Khan MA
    Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
    Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
    Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. STUDIES OF THE CRYSTALLINE FORM OF CEFUROXIME AXETIL: IMPLICATIONS FOR ITS COMPATIBILITY WITH EXCIPIENTS.
    Talaczynska A; Mizera M; Szybowicz M; Nowicka AB; Garbacki P; Paczkowska M; Zalewski P; Kozak M; Oszczapowicz I; Jelinska A; Cielecka-Piontek J
    Acta Pol Pharm; 2016 Sep; 73(5):1299-1309. PubMed ID: 29638070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of amorphous cyclodextrin derivatives on aceclofenac release from directly compressible tablets.
    Dahiya S; Pathak K
    Pharmazie; 2007 Apr; 62(4):278-83. PubMed ID: 17484283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-step preparation and deagglomeration of itraconazole microflakes by supercritical antisolvent method for dissolution enhancement.
    Sathigari SK; Ober CA; Sanganwar GP; Gupta RB; Babu RJ
    J Pharm Sci; 2011 Jul; 100(7):2952-65. PubMed ID: 21344415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The stability of the amorphous form of cefuroxime axetil in solid state.
    Jelińska A; Dudzińska I; Zajac M; Oszczpowicz I
    J Pharm Biomed Anal; 2006 Jun; 41(3):1075-81. PubMed ID: 16563687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticle formation and growth during in vitro dissolution of ketoconazole solid dispersion.
    Kanaujia P; Lau G; Ng WK; Widjaja E; Hanefeld A; Fischbach M; Maio M; Tan RB
    J Pharm Sci; 2011 Jul; 100(7):2876-85. PubMed ID: 21290385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of particle size and preparation methods on the physical and chemical stability of amorphous simvastatin.
    Zhang F; Aaltonen J; Tian F; Saville DJ; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):64-70. PubMed ID: 18703139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.
    Zhang J; Huang Y; Liu D; Gao Y; Qian S
    Eur J Pharm Sci; 2013 Mar; 48(4-5):740-7. PubMed ID: 23305994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement on solubility of fluticasone propionate with cyclodextrins by mechanochemical activation.
    Dai J; Liang X; Su W
    Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):799-806. PubMed ID: 25796157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicomponent crystals of gliclazide and tromethamine: preparation, physico-chemical, and pharmaceutical characterization
    Bruni G; Berbenni V; Maggi L; Mustarelli P; Friuli V; Ferrara C; Pardi F; Castagna F; Girella A; Milanese C; Marini A
    Drug Dev Ind Pharm; 2018 Feb; 44(2):243-250. PubMed ID: 28956461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K; Reddy H; Murthy RS
    AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
    Szabó P; Sebe I; Stiedl B; Kállai-Szabó B; Zelkó R
    J Pharm Biomed Anal; 2015 Nov; 115():359-67. PubMed ID: 26280924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoprecipitation with sonication for enhancement of oral bioavailability of furosemide.
    Sahu BP; Das MK
    Acta Pol Pharm; 2014; 71(1):129-37. PubMed ID: 24779201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.